Emcure Pharmaceuticals Limited

Emcure Pharmaceuticals Limited (India) holds 105 active US FDA Type II Drug Master Files and 19 inactive, has DMF or CEP filings on record for 40 active ingredients, holds 0 active Type IV (excipient) Drug Master Files and is linked to 4 FDA-registered manufacturing sites. 28 FDA enforcement records are linked to it.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “Emcure Pharmaceuticals Limited: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/emcure-pharmaceuticals-limited

Overview

Emcure Pharmaceuticals Limited is an Indian pharmaceutical company engaged in developing, manufacturing, and marketing a broad range of pharmaceutical products globally. Emcure is known for its diverse therapeutic product offerings and innovation-driven approach in health solutions.

Core services & business areas

ManufacturingResearch and DevelopmentMarketing and Sales

Therapeutic areas

Active ingredients with DMF or CEP filings

Substances for which Emcure Pharmaceuticals Limited holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.

API / Drug Master Files

Emcure Pharmaceuticals Limited holds 105 active (124 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.

  • LENACAPAVIR SODIUMActive2026-03-06
  • TAPINAROFActive2025-08-29
  • BENAZEPRIL HYDROCHLORIDE USPActive2025-03-28
  • HYDROXYZINE PAMOATE USPActive2024-12-31
  • HYDROXYZINE HYDROCHLORIDE USPActive2024-03-04
  • BUSPIRONE HYDROCHLORIDE USPActive2023-05-31
  • AMIODARONE HYDROCHLORIDE USPActive2023-05-11
  • TENOFOVIR DISOPROXIL FUMARATEActive2022-07-29
  • ERIBULIN MESYLATEActive2021-12-28
  • LISINOPRIL USPActive2021-03-31
  • SULFAMETHOXAZOLE USPActive2021-03-19
  • AMINOCAPROIC ACID USPActive2020-02-07
  • CHLORPROMAZINE HYDROCHLORIDE USPActive2019-12-31
  • PENTAMIDINE ISETHIONATE USPActive2019-06-15
  • ADENOSINE USPActive2019-05-21
  • MYCOPHENOLATE SODIUM USPActive2019-03-25
  • ARSENIC TRIOXIDEActive2019-02-28
  • ISOSULFAN BLUEActive2018-09-28
  • TREPROSTINILActive2018-09-24
  • DOLUTEGRAVIR SODIUMActive2018-09-24
  • METOCLOPRAMIDE HYDROCHLORIDE USPActive2018-08-03
  • THIOTEPA USPActive2018-06-12
  • FOSCARNET SODIUM USPActive2018-03-30
  • ETHACRYNIC ACID USPActive2018-01-31
  • TENOFOVIR ALAFENAMIDE FUMARATEActive2017-12-29
  • ISOPROTERENOL HYDROCHLORIDE USPActive2017-10-18
  • BEXAROTENEActive2017-10-03
  • DOFETILIDE USPActive2017-08-10
  • TRIENTINE HYDROCHLORIDE USPActive2017-02-23
  • PROCHLORPERAZINE EDISYLATE USPActive2016-12-26
  • MIDODRINE HYDROCHLORIDE USPActive2016-11-07
  • PHYTONADIONE USPActive2016-09-17
  • PALIPERIDONE USPActive2016-03-31
  • TERIFLUNOMIDEActive2016-03-29
  • ROPIVACAINE HYDROCHLORIDE USP (PROCESS II)Active2016-02-01
  • MILRINONE USPActive2015-11-23
  • CYCLOPHOSPHAMIDE USPActive2015-09-30
  • KETOROLAC TROMETHAMINE USPActive2015-09-30
  • SODIUM NITROPRUSSIDE USPActive2015-09-01
  • FELBAMATE USPActive2015-06-26
  • TOLTERODINE TARTRATEActive2015-03-16
  • SM ARG-IActive2014-12-02
  • PEMETREXED DISODIUM HEMIPENTAHYDRATEActive2014-10-09
  • (S)- METHYL-3- (4-BIS(2-HYDROXYETHYL) AMINO) PHENYL) -2 - (TERT- BUTOXYCARBONYLAMINO) PROPANOATEActive2014-10-01
  • 4'-ACETYLOXY 2, 4-DIFLUOROBIPHENYLActive2014-07-16
  • NEOSTIGMINE METHYLSULFATE USPActive2014-07-08
  • FINGOLIMOD HYDROCHLORIDE USPActive2014-06-19
  • IRON SUCROSE COMPLEX SOLUTIONActive2014-05-30
  • DEXMEDETOMIDINE HYDROCHLORIDE USPActive2014-03-18
  • FLECAINIDE ACETATE USPActive2014-01-28

Showing the 50 most relevant of 124 Drug Master Files (active first). The full list is in the FDA DMF list.

Excipient Drug Master Files

Emcure Pharmaceuticals Limited holds 0 active (1 total) FDA Type IV Drug Master File. A Type IV DMF covers an excipient, colourant or flavour, not an active ingredient; these are counted separately from the API filings above.

  • PREMIX FOR BUSULFAN (WITHOUT A)Inactive2012-04-01

Registered manufacturing sites (4)

Physical sites registered with the US FDA and resolved to Emcure Pharmaceuticals Limited, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.

FDA compliance signals

28 FDA enforcement records linked to this company.

  • 4832026-05-15

    Procedures for sterile drug products

  • 4832026-05-15

    Computer control of master formula records

  • 4832026-05-15

    Complaint Handling Procedure

  • 4832026-05-15

    Scientifically sound laboratory controls

  • 4832026-05-15

    Validation lacking for sterile drug products

  • 4832026-05-15

    Investigations of discrepancies, failures

  • 4832026-05-15

    Equipment Design, Size and Location

  • 4832024-04-05

    Establishment of calibration procedures

  • warning_letter2019-08-02

    FDA Warning Letter (drug product)

  • 4832019-02-20

    Procedures not in writing, fully followed

  • 4832019-02-20

    Complete Test Data

  • 4832019-02-20

    Environmental Monitoring System

  • 4832019-02-20

    Sterility/pyrogens - test methods written, followed

  • 4832019-02-20

    Investigations of discrepancies, failures

  • 4832019-02-20

    Procedures for sterile drug products

  • warning_letter2016-03-03

    FDA Warning Letter (drug product)

  • 4832015-02-04

    Cleaning System

  • 4832015-02-04

    Procedures for sterile drug products

  • 4832015-02-04

    Validation lacking for sterile drug products

  • 4832015-02-04

    SOPs not followed / documented

  • 4832015-02-04

    Environmental Monitoring System

  • 4832015-02-04

    Investigations of discrepancies, failures

  • 4832015-02-04

    Scientifically sound laboratory controls

  • 4832015-02-04

    Calibration/Inspection/Checking not done

  • 4832015-02-04

    Aseptic Processing Area

  • 4832015-02-04

    Complete test data included in records

  • 4832015-02-04

    Computer control of master formula records

  • 4832015-02-04

    Cleaning / Sanitizing / Maintenance

For suppliers

Is this Emcure Pharmaceuticals Limited?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.